CJMB.NASDAQCallan Jmb INC

S-1: Callan JMB Inc. Files for $6.9 Million IPO to Fuel Cold Chain Logistics Expansion

Sentiment:

S-1 Registration Statement


Callan JMB Inc., a vertically integrated logistics and fulfillment company specializing in cold chain solutions for the life sciences industry, has filed for an initial public offering to raise $6.9 million.

Capital raiseThe company is offering 1,280,000 shares of common stock in this initial public offering.The company currently expects the initial public offering price to be between $4.00 and $6.00 per share.The company has granted a 45-day option to the underwriters to purchase up to 192,000 additional shares of common stock, representing 15% of the shares of common stock sold in this offering, solely to cover over-allotments, if any.The company has agreed to issue to the representatives of the underwriters Representatives Warrants to purchase a number of shares of our common stock equal to 5% of the aggregate number of shares of common stock sold in this offering.
Worse than expectedRevenue for the six months ended June 30, 2024 was $3,776,289 as compared to $8,604,057 for the six months ended June 30, 2023, a decrease of $4,827,768.Net income (loss) for the six months ended June 30, 2024 was $(193,609) as compared to $2,285,567 for the six months ended June 30, 2023.

Summary

  • Callan JMB Inc., a Nevada corporation, has filed a registration statement for an initial public offering.
  • The company aims to raise $6.9 million by offering 1,280,000 shares of common stock, with an expected price between $4.00 and $6.00 per share.
  • The company provides thermal management logistics solutions to the life sciences industry, utilizing proprietary packaging, IT, and cold chain logistics expertise.
  • Callan JMB's solutions are positioned as disruptive alternatives to traditional methods like dry ice and liquid nitrogen.
  • The company has applied to list its common stock on the Nasdaq Capital Market under the symbol CJMB.
  • Alexander Capital, L.P. is acting as the sole book-runner for the offering.
  • Wayne Williams, the CEO, owns 75% of the company's common stock, and Dr. David Croyle, the Chief Medical Officer, owns 25%.
  • Post-IPO, Williams and Croyle will hold approximately 60% and 20% of the voting power, respectively.
  • The company is classified as an emerging growth company and a smaller reporting company, allowing for reduced reporting requirements.
  • The company intends to use the net proceeds from this offering primarily for sales support, marketing, customer expansion and general corporate purposes, including working capital.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While the company highlights its strengths and growth opportunities, it also acknowledges significant risks and a recent decline in revenue and profitability. The IPO itself is a positive step, but the company's dependence on a few key customers and the limited experience of its management team are causes for concern.

Positives

  • The company offers a comprehensive and integrated solution for cold chain logistics, which is a growing market.
  • The company's proprietary technology, including Ship2Q and Sentry, provides a competitive advantage.
  • The company has long-standing relationships with Fortune 500 firms, the City of Chicago, NATO, the UN, and certain other government agencies at all levels.
  • The company is committed to environmental sustainability, as the packaging we arrange for is reusable which reduces waste and cost as compared to traditional, single-use packaging.

Negatives

  • The company is subject to concentration risk, with a significant portion of revenue derived from a few key customers.
  • The company has a limited operating history, which may result in increased risks, uncertainties, expenses, and difficulties, and makes it difficult to evaluate our prospects.
  • The company's management team has limited experience managing a public company.
  • The company has a limited sales force and may be dependent on the proceeds of this offering to fund additional sales personnel.

Risks

  • The company operates in a heavily regulated environment, and failure to comply with regulations could harm its business.
  • The company faces intense competition from local, regional, and national firms.
  • The company may need to raise substantial additional capital in the future in order to execute our business plan and help us and our collaboration partners fund the development and commercialization of our products.
  • The company depends on its executive team and other employees to manage the business and the loss of one or more of these employees or an inability to attract and retain highly skilled employees could materially harm our business.
  • The company's founder and CEO has control over key decision-making as a result of his control of a majority of our voting shares of common stock.
  • The company's common stock may potentially experience rapid and substantial price volatility, and price decline, which may make it difficult for prospective investors to assess what we believe to be the value of our common stock.

Future Outlook

The company expects its operations to vary seasonally, with revenue typically highest in the third and fourth calendar quarters and lowest in the first and second calendar quarters. The company intends to explore other large market industries as part of its growth strategy, including the high-end food packaging industry.

Management Comments

  • We view our solutions as disruptive to the older technologies of dry ice and liquid nitrogen, in that our solutions are comprehensive and combine our competencies in configurations that are customized to our clients requirements.
  • We strive to be recognized as the premier provider of logistics and fulfillment of a broad range of value-added services based upon the breadth of those services, quality, responsiveness, customer service, information technologies, safety, and cost effectiveness.

Industry Context

The company operates in the rapidly growing temperature-sensitive packaging and shipping segment of the logistics industry, driven by the increasing demand for biological materials and pharmaceuticals requiring cryogenic temperatures. The company expects that industry standards and regulations will be introduced globally, requiring more comprehensive tracking and validation of shipping temperatures.

Comparison to Industry Standards

  • While the document does not provide specific comparisons to industry standards, it mentions competitors such as cryogenic equipment manufacturers, shippers, and specialty couriers.
  • The document states that no one competitor directly competes with our full suite of offerings as a result of the Companys breadth of service offerings.
  • The document does not provide specific comparisons to global benchmarks.

Legal Proceedings

  • In May 2024, the Company received a demand letter alleging that the Company breached the terms of a customer service agreement with one of its vendors that it did business with in a prior year.
  • The vendor alleged that the Company improperly terminated the agreement without proper notice and owes that vendor $507,573 in damages.
  • The Company responded to the vendors demand letter and asserts that it only owes the vendor the sum of $85,000, which is included in the Companys accounts payable as of June 30, 2024.

Related Party Transactions

  • The company leases its office space from a related party under a lease agreement that commenced on April 1, 2024, and expires on December 31, 2029, with a monthly base rent of $15,425.
  • The company leases additional two warehouse spaces from related parties under lease agreements that expire on September 30, 2025 and December 31, 2025, with respective monthly base rents of $3,150 and $7,500.

Stakeholder Impact

  • Shareholders will experience dilution as a result of the IPO.
  • Employees may benefit from the company's growth and expansion plans.
  • Customers may benefit from improved services and expanded offerings.
  • Suppliers may benefit from increased business volume.

Next Steps

  • The company expects to list its common stock on the Nasdaq Capital Market under the symbol CJMB, pending approval.
  • The company intends to use the net proceeds of this offering primarily for sales support, marketing, customer expansion and general corporate purposes, including working capital.

Key Dates

DateDescription
December 27, 2006Coldchain Technology Services, LLC (CTS) was formed in the state of Texas.
December 7, 2010The Company received a trademark registration for Ship2Q.
January 1, 2019The City of Chicago awarded the company a seven-year pallet storage contract.
December 3, 2022The City of Chicago awarded the company a seven-year SCADA contract.
January 24, 2024Callan JMB Inc. was formed in Nevada.
February 14, 2024The company entered into a reorganization agreement with Coldchain Technology Services, LLC.
April 1, 2024The company entered into a lease agreement with Warehouse Asset Management, LLC.
October 1, 2024The company entered into employment agreements with Eric Kash, Jeff Appleman, and David J. Croyle.
October 15, 2024The company entered into an employment agreement with Wayne Williams.
October 25, 2024The company's Board and stockholders approved the 2024 Equity Incentive Plan.

Keywords

cold chain logistics, thermal management, life sciences, vertically integrated, fulfillment, logistics, IPO, Sentry, Ship2Q, packaging

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.